基本信息
浏览量:36
职业迁徙
个人简介
Dr. Bardia is a board-certified medical oncologist interested in developing successful targeted and personalized therapies to improve the outcomes of patients and families afflicted with breast cancer. The accurate identification of target is crucial for success of targeted therapies, and Dr. Bardia is involved in the clinical development of tumor genotyping as well as circulating tumor cells (CTCs) to facilitate accurate diagnosis, therapy selection, and real-time monitoring of breast cancer. In collaboration the CTC center and Haber lab, his research on molecular changes in CTCs in metastatic breast cancer has elucidated the role of epithelial-mesenchymal transition, and provided proof-of-principle that ex-vivo CTC culture and molecular drug testing is feasible in breast cancer. Dr. Bardia is the principal investigator of clinical trials investigating the role of targeted therapy combinations for breast cancer. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.
研究兴趣
论文共 578 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Aditya Bardia,Sheng Sun,Nayana Thimmiah,James T. Coates,Bogang Wu, Rachel O. Abelman,Laura Spring,Beverly Moy,Phoebe Ryan, Mark N. Melkonyan, Ann Partridge,Dejan Juric,
Clinical Cancer Research (2024)
Rebecca S. Heist,Jacob Sands,Aditya Bardia,Toshio Shimizu,Aaron Lisberg,Ian Krop,Noboru Yamamoto,Takahiro Kogawa, Saba Al-Hashimi,Simon S.M. Fung,Anat Galor, Francesca Pisetzky,
Cancer Treatment Reviews (2024): 102720-102720
Annals of oncology : official journal of the European Society for Medical Oncologyno. 5 (2024): 481-481
Elad Horwitz,Taronish D. Dubash, Annamaria Szabolcs,Ben S. Wittner,Johannes Kreuzer,Robert Morris,Aditya Bardia,Brian Chirn,Devon Wiley,Dante Che, Hunter C. Russel, Xcanda Ixchel Herrera Lopez,
biorxiv(2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn